1-3 of 3
Kevin Allen, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Preclinical Development of an Actinium-225-Labeled Antibody Radio-Conjugate Directed Against CD45 for Targeted Conditioning and Radioimmunotherapy

Dale Ludwig, PhD BS, Ruth Bryan, Wojciech Dawicki, PhD, Eileen M Geoghegan, Qing Liang, PhD, Sandesh Seth, MS, MBA, Mamata Gokhale, Mark S. Berger, MD, Vijay Reddy, MD PhD, Ravendra Garg, Kevin Allen, PhD, Ekaterina Dadachova
Journal: Blood
Blood (2019) 134 (Supplement_1): 5601.
https://doi.org/10.1182/blood-2019-128678
Published: 2019
Journal Articles

Modeling Targeted Lymphodepletion with Radiolabeled CD45 Antibody As a Promising Preparative Regimen Prior to Adoptive Cell Therapy or CAR-T

Dale L Ludwig, PhD BS, Mark S. Berger, MD, Dadachova Ekaterina, PhD, Kevin Allen, PhD, Wojciech Dawicki
Journal: Blood
Blood (2018) 132 (Supplement 1): 5682.
https://doi.org/10.1182/blood-2018-99-119740
Published: 2018
Journal Articles

Actinium Labeled Daratumumab Demonstrates Enhanced Killing of Multiple Myeloma Cells over Naked Daratumumab

Mark S. Berger, MD, Keisha Thomas, PhD, Dadachova Ekaterina, PhD, Mackenzie Malo, M.Sc., Rubin Jiao, PhD, Kevin Allen, PhD, Colin Clarke
Journal: Blood
Blood (2017) 130 (Supplement 1): 4427.
https://doi.org/10.1182/blood.V130.Suppl_1.4427.4427
Published: 2017